

Dhaka : North South University (NSU), through its Department of Pharmaceutical Sciences, hosted the prestigious European Society for Medical Oncology (ESMO) Examination 2026 in Dhaka, Bangladesh, on 24 October 2026, marking the second time the examination has been held in the country. The examination took place simultaneously at approved centers worldwide from 13:00 to 15:30 Central European Summer Time (CEST).
This milestone represents a significant achievement for Bangladesh’s oncology community, enabling local medical professionals to participate in one of the most respected international examinations in medical oncology without having to travel abroad. Hosting the examination in Bangladesh is expected to encourage greater participation among local candidates and further strengthen the country’s commitment to advancing cancer care, medical education, and professional development.
Widely recognized as a benchmark for professional knowledge and competence in medical oncology, the ESMO Examination assesses candidates’ clinical knowledge and decision-making skills. A total of 61 doctors from Bangladesh participated in the ESMO Examination 2026. Candidates who successfully pass the examination earn an internationally recognized qualification that reflects their professional competence and supports their contributions to oncology practice at both national and international levels.
The administration of the examination at NSU followed ESMO’s established protocols to ensure fairness, transparency, and examination security. Strict confidentiality procedures were maintained throughout the process, and examination materials were handled securely in accordance with ESMO’s requirements.
Founded in 1975, the European Society for Medical Oncology (ESMO) is a leading professional organization dedicated to advancing medical oncology worldwide. Representing more than 30,000 members across over 170 countries, ESMO plays a pivotal role in promoting excellence in cancer care, education, and research. Through initiatives such as the ESMO Examination, the organization continues to support the professional development of oncology specialists and contribute to improving cancer outcomes globally.
